Cargando…
In utero nanoparticle delivery for site-specific genome editing
Genetic diseases can be diagnosed early during pregnancy, but many monogenic disorders continue to cause considerable neonatal and pediatric morbidity and mortality. Early intervention through intrauterine gene editing, however, could correct the genetic defect, potentially allowing for normal organ...
Autores principales: | Ricciardi, Adele S., Bahal, Raman, Farrelly, James S., Quijano, Elias, Bianchi, Anthony H., Luks, Valerie L., Putman, Rachael, López-Giráldez, Francesc, Coşkun, Süleyman, Song, Eric, Liu, Yanfeng, Hsieh, Wei-Che, Ly, Danith H., Stitelman, David H., Glazer, Peter M., Saltzman, W. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018676/ https://www.ncbi.nlm.nih.gov/pubmed/29946143 http://dx.doi.org/10.1038/s41467-018-04894-2 |
Ejemplares similares
-
Nanoparticle‐mediated genome editing in single‐cell embryos via peptide nucleic acids
por: Putman, Rachael, et al.
Publicado: (2022) -
Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing
por: Ricciardi, Adele S., et al.
Publicado: (2018) -
Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities
por: Quijano, Elias, et al.
Publicado: (2017) -
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery
por: Bahal, Raman, et al.
Publicado: (2016) -
Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy
por: Gupta, Anisha, et al.
Publicado: (2017)